Free Answer to Counterclaim - District Court of Delaware - Delaware


File Size: 34.0 kB
Pages: 6
Date: February 26, 2008
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 1,003 Words, 6,694 Characters
Page Size: Letter (8 1/2" x 11")
URL

https://www.findforms.com/pdf_files/ded/39559/40.pdf

Download Answer to Counterclaim - District Court of Delaware ( 34.0 kB)


Preview Answer to Counterclaim - District Court of Delaware
Case 1:08-cv-00021-GMS-LPS

Document 40

Filed 02/26/2008

Page 1 of 6

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) ) ) ) ) ) ) Plaintiffs, ) ) v. ) ) COBALT LABORATORIES INC., LUPIN ) PHARMACEUTICALS, INC., LUPIN LTD., ) ) ORCHID PHARMACEUTICALS INC., ) ORCHID CHEMICALS & PHARMACEUTICALS LTD. (d/b/a ORCHID ) ) HEALTHCARE), TEVA ) PHARMACEUTICALS USA, INC., ) UPSHER-SMITH LABORATORIES, INC., ) WOCKHARDT USA INC., and ) WOCKHARDT LIMITED, ) ) Defendants. ) FOREST LABORATORIES, INC., FOREST LABORATORIES HOLDINGS, LTD., MERZ PHARMA GMBH & CO. KGAA, and MERZ PHARMACEUTICALS GMBH,

C.A. No. 08-021 (GMS)

PLAINTIFFS' REPLY TO DEFENDANTS LUPIN PHARMACEUTICALS, INC.'S AND LUPIN LTD.'S COUNTERCLAIMS Plaintiffs Forest Laboratories, Inc. and Forest Laboratories Holdings, Ltd. (collectively "Forest") and Merz Pharma GmbH & Co. KGaA and Merz Pharmaceuticals GmbH (collectively "Merz"), for their Reply to the numbered paragraphs of the Counterclaims of Defendants Lupin Pharmaceuticals, Inc. and Lupin Ltd. (collectively "Lupin") (D.I. 35), hereby allege as follows: THE PARTIES 78. 79. Admitted, upon information and belief. Admitted, upon information and belief.

Case 1:08-cv-00021-GMS-LPS

Document 40

Filed 02/26/2008

Page 2 of 6

80. 81. 82. 83. 84.

Admitted. Admitted. Admitted. Admitted. Admitted that Merz is the owner of United States Patent No. 5,061,703

("the `703 patent"), entitled "Adamantane Derivatives in the Prevention and Treatment of Cerebral Ischemia." Denied that the `703 patent or its Reexamination Certificate is attached as an exhibit to Lupin's Counterclaims. 85. Admitted. JURISDICTION AND VENUE 86. Admitted that this Court has subject matter jurisdiction over Lupin's

counterclaims and that Lupin's counterclaims arise under the United States Patent Act, 35 U.S.C. § 1 et seq. Denied that Lupin's counterclaims are "substantial" or that there is any factual or legal basis for them. 87. Denied that this case presents an actual controversy within the meaning of

28 U.S.C. §§ 2201 and 2202. 88. Admitted. THE CONTROVERSY 89. 90. Admitted, upon information and belief. Admitted insofar as "the present action" refers to claims brought by Forest

and Merz (collectively "Plaintiffs") against Lupin and other defendants. Denied insofar as "the present action" refers to Lupin's counterclaims against Plaintiffs.

2

Case 1:08-cv-00021-GMS-LPS

Document 40

Filed 02/26/2008

Page 3 of 6

COUNTERCLAIM COUNT I 91. Plaintiffs restate and incorporate by reference their responses to the

allegations contained in Counterclaim Paragraphs 78-90 as though set forth specifically herein. 92. 93. Denied. Denied. COUNTERCLAIM COUNT II 94. Plaintiffs restate and incorporate by reference their responses to the

allegations contained in Counterclaim Paragraphs 78-93 as though set forth specifically herein. 95. Denied. COUNTERCLAIM COUNT III 96. Plaintiffs restate and incorporate by reference their responses to the

allegations contained in Counterclaim Paragraphs 78-95 as though set forth specifically herein. 97. 98. 99. 100. Admitted. Admitted. Denied. Denied. PRAYER FOR RELIEF Wherefore, Plaintiffs deny that Lupin is entitled to any relief, either as prayed for in its Counterclaims or otherwise. Plaintiffs further deny each allegation contained in Lupin's Counterclaims that was not specifically admitted, denied, or otherwise responded to in this Reply to Defendants Lupin Pharmaceuticals, Inc.'s and Lupin Ltd.'s Counterclaims.

3

Case 1:08-cv-00021-GMS-LPS

Document 40

Filed 02/26/2008

Page 4 of 6

MORRIS, NICHOLS, ARSHT & TUNNELL LLP

/s/ James W. Parrett, Jr. (#4292)
Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) James W. Parrett, Jr. (#4292) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected] [email protected] Attorneys for Plaintiffs Of Counsel: John Desmarais Gerald J. Flattmann, Jr. Melanie R. Rupert KIRKLAND & ELLIS LLP Citigroup Center 153 East 53rd Street New York, NY 10022 (212) 446-4800 F. Dominic Cerrito Daniel L. Malone Eric C. Stops JONES DAY 222 East 41st Street New York, NY 10017 (212) 326-3939 February 26, 2008
1660152

4

Case 1:08-cv-00021-GMS-LPS

Document 40

Filed 02/26/2008

Page 5 of 6

CERTIFICATE OF SERVICE I hereby certify that on February 26, 2008 I electronically filed the foregoing with the Clerk of the Court using CM/ECF, which will send notification of such filing to: Mary B. Matterer, Esquire MORRIS JAMES LLP Kelly E. Farnan, Esquire RICHARDS, LAYTON & FINGER, P.A. Frederick L. Cottrell, III, Esquire Anne Shea Gaza, Esquire RICHARDS, LAYTON & FINGER, P.A. Richard L. Horwitz, Esquire David E. Moore, Esquire POTTER ANDERSON & CORROON LLP Richard D. Kirk, Esquire Ashley B. Stitzer, Esquire BAYARD, P.A. I further certify that I caused to be served copies of the foregoing document on February 26, 2008 upon the following in the manner indicated: Mary B. Matterer, Esquire MORRIS JAMES LLP 500 Delaware Avenue Suite 1500 Wilmington, DE 19801 Counsel for Cobalt Laboratories Inc. William A. Rakoczy, Esquire Paul J. Molino, Esquire Deanne M. Mazzochi, Esquire Neil A. Benchell, Esquire John Polivick, Esquire RAKOCZY MOLINO MAZZOCHI SIWIK LLP 6 West Hubbard Street Suite 500 Chicago, IL 60610 Counsel for Cobalt Laboratories Inc. VIA ELECTRONIC MAIL and HAND DELIVERY

VIA ELECTRONIC MAIL

Case 1:08-cv-00021-GMS-LPS

Document 40

Filed 02/26/2008

Page 6 of 6

Kelly E. Farnan, Esquire RICHARDS, LAYTON & FINGER, P.A. One Rodney Square 920 North King Street Wilmington, DE 19801 Counsel for Wockhardt USA Inc. and Wockhardt Limited Frederick L. Cottrell, III, Esquire Anne Shea Gaza, Esquire RICHARDS, LAYTON & FINGER, P.A. One Rodney Square 920 North King Street Wilmington, DE 19801 Counsel for Upsher-Smith Laboratories Inc. Richard L. Horwitz, Esquire David E. Moore, Esquire POTTER ANDERSON & CORROON LLP 1313 North Market Street ­ 6th Floor Wilmington, DE 19801 Counsel for Orchid Pharmaceuticals Inc. and Orchid Chemicals & Pharmaceuticals Ltd (d/b/a Orchid Healthcare) Richard D. Kirk, Esquire Ashley B. Stitzer, Esquire BAYARD, P.A. 222 Delaware Avenue Suite 900 Wilmington, DE 19801 Counsel for Lupin Pharmaceuticals USA, Inc. and Lupin, Ltd. Douglass C. Hochstetler, Esquire D. Christopher Ohly, Esquire Sailesh K. Patel, Esquire SCHIFF HARDIN LLP 6600 Sears Tower Chicago, IL 60606 Counsel for Lupin Pharmaceuticals USA, Inc. and Lupin, Ltd.

VIA ELECTRONIC MAIL and HAND DELIVERY

VIA ELECTRONIC MAIL and HAND DELIVERY

VIA ELECTRONIC MAIL and HAND DELIVERY

VIA ELECTRONIC MAIL and HAND DELIVERY

VIA ELECTRONIC MAIL

/s/ James W. Parrett, Jr. (#4292)
James W. Parrett, Jr. (#4292) 2